Multiple Factors Suggest Genzyme Still Faces Problems Related To Cerezyme
This article was originally published in The Pink Sheet Daily
Executive Summary
The biotech's decontaminated plant has reopened, but FDA plans to re-inspect the facility. In addition, Genzyme had to discard more in-process Cerezyme than expected and a competitor's investigational drug has received clearance for emergency use by FDA.